SEC EDGAR Filing Information

Form 10-Q -- Quarterly report [Sections 13 or 15(d)]

Period of Report: 2008-12-31
Filing Date Changed: 2009-02-03
Documents: 5

SEC Accession No.
0001193125-09-017197
Filing date: 2009-02-03
Accepted: 2009-02-03 11:55:42

Table of submitted documents:

Seq	Type	Document	Size	Description
1	10-Q	d10q.htm	306128	FORM 10-Q
2	EX-3.1	dex31.htm	66309	RESTATED CERTIFICATE OF INCORPORATION, AS AMENDED
3	EX-31.1	dex311.htm	9250	SECTION 302 CEO CERTIFICATION
4	EX-31.2	dex312.htm	9438	SECTION 302 CFO CERTIFICATION
5	EX-32.1	dex321.htm	4477	SECTION 906 CEO AND CFO CERTIFICATION

		0001193125-09-017197.txt	396965	Complete submission text file

Filer Information:

MYRIAD GENETICS INC (Filer) (0000899923)
IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-26642 | Film No.: 09563680
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Assistant Director 1

Business Address
320 WAKARA WAY
SALT LAKE CITY UT 84108

Mailing Address
320 WAKARA WAY
SALT LAKE CITY UT 84108